Protein detail

PRIO

Major prion protein (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)

Entry name
PRIO
UniProt ID
EVMP confidence score
0.88
Supporting publications (n)
21
Transmembrane count
Protein classification
CD markersDisease related genesHuman disease related genesPlasma proteinsPotential drug targetsPredicted membrane proteinsTransporters
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information11
Protein Names
Major prion protein (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)
Protein Class (7)
CD markersDisease related genesHuman disease related genesPlasma proteinsPotential drug targetsPredicted membrane proteinsTransporters
Protein Function (5)
  • Human disease related genes:Nervous system diseases:Neurodegenerative diseases
  • CD markers
  • Potential drug targets
  • Transporters:Transporter channels and pores
  • Disease related genes
Entrez Gene Symbol
Gene Synonym (6)
AltPrPCD230CJDGSSPRIPPRP
Gene Description
Prion protein
Chromosome
20
Position
4686350-4701590
Supporting publications (n)
21
EVMP confidence score
0.88
Fluorescence & Localization2
Tissue Specificskeletal muscleCell SpecificAlveolar cells type 1
Function & Pathway7
Protein Function (5)
  • Human disease related genes:Nervous system diseases:Neurodegenerative diseases
  • CD markers
  • Potential drug targets
  • Transporters:Transporter channels and pores
  • Disease related genes
Mediation Categories (6)
Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation
Relations & Evidence70

Enzyme-Mediated Modification (2)

2 records.

Substrate Gene SymbolEnzyme Gene SymbolEnzyme UniProt IDResidue TypeResidue OffsetModificationDatabaseReferences
PRNPCDK5Q00535S43phosphorylationSparser_ProtMapperPhosphoSitePhosphoSite_ProtMapperProtMapperProtMapper:19587281
PRNPCDK5R1Q15078S43phosphorylationSparser_ProtMapperProtMapperProtMapper:19587281ProtMapper:25572400

Ligand-Receptor Signaling (63)

63 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
plasma_membraneplasma_membraneCellinkerNoNoNoYesYes
plasma_membraneplasma_membraneOmniPathNoNoNoYesYes
plasma_membraneplasma_membraneOmniPathNoNoNoYesYes
plasma_membrane_transmembraneplasma_membrane_transmembraneCSPANoNoNoYesYes
plasma_membrane_transmembraneplasma_membrane_transmembraneCSPANoNoNoYesYes
plasma_membrane_transmembraneplasma_membrane_transmembraneOmniPathNoNoNoYesYes
plasma_membrane_transmembraneplasma_membrane_transmembraneOmniPathNoNoNoYesYes
plasma_membrane_peripheralplasma_membrane_peripheralCSPANoNoNoYesYes
plasma_membrane_peripheralplasma_membrane_peripheralCSPANoNoNoYesYes
plasma_membrane_peripheralplasma_membrane_peripheralOmniPathNoNoNoYesYes
Page 5 of 7PreviousNext

Regulatory Interaction Network (1)

1 record.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
CDK5Q00535PRIOP04156YesYesNoiPTMnetSIGNORProtMapperPhosphoSitePhosphoSite_ProtMapperPhosphoSite:25572400SIGNOR:19587281PhosphoSite:24360565

Protein Complex Composition (3)

3 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
PRNP homo-oligomer complexPRNPP041562CORUMPDBPDB:3nhdPDB:3md4PDB:3hesPDB:3md5PDB:7rl4PDB:3nhcPDB:6lniCORUM:2007PDB:3herPDB:7dwvPDB:3heqPDB:6uurPDB:3hj5PDB:4e1hPDB:7un5PDB:4e1iPDB:7rvjPDB:6pq5PDB:7umq16148934
PRNP-ApolopoproteinE3 complexAPOEPRNPP02649P041561:1CompleatCompleat:HC294916764853
PRNP-ApolopoproteinE3 complexPRNPQ13791P04156Q137910:0CORUMCORUM:108816764853

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationUltrafiltration / Tangential Flow FiltrationMass spectrometry137786918
Sequence, Structure & Domains14

Sequences

Length
253
Mass
27,661
Sequence
MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG
Alternative Products
Event=Alternative initiation; Named isoforms=2; Name=1; Synonyms=PrP; IsoId=P04156-1; Sequence=Displayed; Name=3; Synonyms=AltPrP; IsoId=F7VJQ1-1; Sequence=External

3D Structural Models

Turn
74..76; 114..117; 171..173; 193..195; 223..225; 228..230
Helix
144..153; 154..156; 166..168
Beta Strand
63..67; 70..73; 79..82; 92..95; 99..101; 109..112; 118..122; 125..127; 128..131; 133..135; 138..140; 141..143; 159..163; 178..181; 182..185; 189..192; 196..202; 205..210; 212..215
3D Structure
Electron microscopy (11); NMR spectroscopy (34); X-ray crystallography (25)

Domain & Motif Annotations

Compositional Bias
52..95; Gly residues
Repeat
51..59; 1; 60..67; 2; 68..75; 3; 76..83; 4; 84..91; 5
Domain (CC)
The normal, monomeric form, PRPN(C), has a mainly alpha-helical structure. Misfolding of this form produces a disease-associated, protease-resistant form, PRPN (Sc), accompanied by a large increase of the beta-sheet content and formation of amyloid fibrils. These fibrils consist of a cross-beta spine, formed by a steric zipper of superposed beta-strands. Disease mutations may favor intermolecular contacts via short beta strands, and may thereby trigger oligomerization. In addition, the heparan-sulfate proteoglycan, GPC1, promotes the association of PRPN (C) to lipid rafts and appears to facilitate the conversion to PRPN (Sc).; DOMAIN: Contains an N-terminal region composed of octamer repeats. At low copper concentrations, the sidechains of His residues from three or four repeats contribute to the binding of a single copper ion. Alternatively, a copper ion can be bound by interaction with the sidechain and backbone amide nitrogen of a single His residue. The observed copper binding stoichiometry suggests that two repeat regions cooperate to stabilize the binding of a single copper ion. At higher copper concentrations, each octamer can bind one copper ion by interactions with the His sidechain and Gly backbone atoms. A mixture of binding types may occur, especially in the case of octamer repeat expansion. Copper binding may stabilize the conformation of this region and may promote oligomerization.
Region
23..230; Interaction with GRB2, ERI3 and SYN1; 23..38; Interaction with ADGRG6; 26..108; Disordered; 51..91; 5 X 8 AA tandem repeats of P-H-G-G-G-W-G-Q
Protein Families
Prion family
Sequence Similarities
Belongs to the prion family.
Clinical Relevance7
Disease Involvement (2)
AmyloidosisDisease variant
Drug Targets
Literature-reported target
Interaction Protein (9)
ENSG00000022267ENSG00000103152ENSG00000129195ENSG00000155760ENSG00000163823ENSG00000164251ENSG00000169252ENSG00000169403ENSG00000173846
Interaction Count
9
Interaction Dataset
intact_biogrid
Supporting Publications19
PMIDTitleAbstract
23161513Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.Exosomes from mutant KRAS cells contain many tumor-promoting proteins, including KRAS, EGFR, SRC family kinases, and integrins.
27894104Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.No abstract available
28369848End stage renal disease-induced hypercalcemia may promote aortic valve calcification via Annexin VI enrichment of valve interstitial cell derived-matrix vesicles.No abstract available
28986585Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics.No abstract available
29045505Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.Proteomic analysis of the exosome 'surfaceome' revealed multiple PDAC-specific biomarker candidates: CLDN4, EPCAM, CD151, LGALS3BP, HIST2H2BE, and HIST2H2BF. Droplet digital PCR was used on 74 patients (136 total exosome samples) to determine baseline KRAS mutation call rates while patients were on therapy. KRAS mutations in total exosomes were detected in 44.1% of patients undergoing active therapy compared with 73.0% following exosome capture using the selected biomarkers.
31018934Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease.No abstract available
32089743Human umbilical cord mesenchymal stromal cells-derived extracellular vesicles exert potent bone protective effects by CLEC11A-mediated regulation of bone metabolism.No abstract available
32284825Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine.No abstract available
32795414Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.Among traditional exosome markers, CD9, HSPA8, ALIX, and HSP90AB1 represent pan-EVP markers, while ACTB, MSN, and RAP1B are novel pan-EVP markers.
34186243A Reductionist Approach Using Primary and Metastatic Cell-Derived Extracellular Vesicles Reveals Hub Proteins Associated with Oral Cancer Prognosis.No abstract available
Page 1 of 2Next